Did last month’s episode leave you wanting to learn more about the rapidly developing space of psychedelic compounds’ use in treating psychiatric conditions like Major Depressive Disorder, Generalized Anxiety Disorder and various addiction disorders? Drew & Liv had a feeling you would, so look no further than this episode, where they bring on Doug Drysdale, CEO of Cybin Inc., to discuss his company’s mission and progress in this space. Throughout this episode, you will learn how psilocybi...
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from Science in Society
The Science of Community & Chem-Impex with Jamie Shah
The Science of Endocrine Disruptors with Drs. Neff & Mourikes
The Science of Precision Nutrition with Ari Tulla
The Science of Precision Oncology with Dr. Kevin Parker
Get summaries like this every morning.
Free AI-powered recaps of Science in Society and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.